FRESENIUS MEDICAL CARE-ADR (FMS) Stock Fundamental Analysis
USA • New York Stock Exchange • NYSE:FMS • US3580291066
22.7 USD
+0.18 (+0.8%)
At close: Jan 30, 2026
22.7 USD
0 (0%)
After Hours: 1/30/2026, 8:04:00 PM
FMS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of FMS get a neutral evaluation. Nothing too spectacular is happening here. FMS scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
- In the past year FMS was profitable.
- FMS had a positive operating cash flow in the past year.
- FMS had positive earnings in each of the past 5 years.
- Each year in the past 5 years FMS had a positive operating cash flow.
1.2 Ratios
- FMS has a Return On Assets (2.33%) which is comparable to the rest of the industry.
- With a decent Return On Equity value of 5.55%, FMS is doing good in the industry, outperforming 61.16% of the companies in the same industry.
- FMS has a Return On Invested Capital (3.95%) which is in line with its industry peers.
- The Average Return On Invested Capital over the past 3 years for FMS is significantly below the industry average of 9.16%.
- The 3 year average ROIC (3.14%) for FMS is below the current ROIC(3.95%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROIC | 3.95% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
- FMS has a Profit Margin of 3.66%. This is in the better half of the industry: FMS outperforms 73.79% of its industry peers.
- FMS's Profit Margin has declined in the last couple of years.
- FMS has a better Operating Margin (7.19%) than 72.82% of its industry peers.
- In the last couple of years the Operating Margin of FMS has declined.
- FMS has a Gross Margin (25.00%) which is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of FMS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FMS is destroying value.
- The number of shares outstanding for FMS remains at a similar level compared to 1 year ago.
- The number of shares outstanding for FMS has been reduced compared to 5 years ago.
- The debt/assets ratio for FMS has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 1.78, we must say that FMS is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of FMS (1.78) is comparable to the rest of the industry.
- The Debt to FCF ratio of FMS is 5.97, which is a neutral value as it means it would take FMS, 5.97 years of fcf income to pay off all of its debts.
- FMS has a Debt to FCF ratio of 5.97. This is in the better half of the industry: FMS outperforms 63.11% of its industry peers.
- A Debt/Equity ratio of 0.73 indicates that FMS is somewhat dependend on debt financing.
- The Debt to Equity ratio of FMS (0.73) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Altman-Z | 1.78 |
ROIC/WACC0.78
WACC5.08%
2.3 Liquidity
- FMS has a Current Ratio of 1.36. This is a normal value and indicates that FMS is financially healthy and should not expect problems in meeting its short term obligations.
- FMS's Current ratio of 1.36 is in line compared to the rest of the industry. FMS outperforms 50.49% of its industry peers.
- A Quick Ratio of 1.00 indicates that FMS may have some problems paying its short term obligations.
- With a Quick ratio value of 1.00, FMS is not doing good in the industry: 65.05% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
- FMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.77%, which is quite good.
- The Earnings Per Share has been decreasing by -6.43% on average over the past years.
- Looking at the last year, FMS shows a small growth in Revenue. The Revenue has grown by 2.10% in the last year.
- The Revenue has been growing slightly by 2.04% on average over the past years.
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
3.2 Future
- The Earnings Per Share is expected to grow by 12.37% on average over the next years. This is quite good.
- The Revenue is expected to grow by 3.81% on average over the next years.
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y12.37%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y3.81%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 10.18 indicates a reasonable valuation of FMS.
- Based on the Price/Earnings ratio, FMS is valued cheaper than 91.26% of the companies in the same industry.
- FMS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.32.
- FMS is valuated reasonably with a Price/Forward Earnings ratio of 9.23.
- Based on the Price/Forward Earnings ratio, FMS is valued cheaper than 90.29% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 25.57. FMS is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.18 | ||
| Fwd PE | 9.23 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, FMS is valued cheaply inside the industry as 88.35% of the companies are valued more expensively.
- 92.23% of the companies in the same industry are more expensive than FMS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.37 | ||
| EV/EBITDA | 6.37 |
4.3 Compensation for Growth
- FMS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as FMS's earnings are expected to grow with 13.16% in the coming years.
PEG (NY)0.47
PEG (5Y)N/A
EPS Next 2Y12.96%
EPS Next 3Y13.16%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 3.85%, FMS has a reasonable but not impressive dividend return.
- FMS's Dividend Yield is rather good when compared to the industry average which is at 0.47. FMS pays more dividend than 99.03% of the companies in the same industry.
- FMS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.85% |
5.2 History
- The dividend of FMS has a limited annual growth rate of 0.31%.
- FMS has paid a dividend for at least 10 years, which is a reliable track record.
- FMS has decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.31%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- 58.83% of the earnings are spent on dividend by FMS. This is a bit on the high side, but may be sustainable.
- FMS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.83%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
FRESENIUS MEDICAL CARE-ADR / FMS FAQ
What is the fundamental rating for FMS stock?
ChartMill assigns a fundamental rating of 5 / 10 to FMS.
Can you provide the valuation status for FRESENIUS MEDICAL CARE-ADR?
ChartMill assigns a valuation rating of 8 / 10 to FRESENIUS MEDICAL CARE-ADR (FMS). This can be considered as Undervalued.
What is the profitability of FMS stock?
FRESENIUS MEDICAL CARE-ADR (FMS) has a profitability rating of 5 / 10.
What is the expected EPS growth for FRESENIUS MEDICAL CARE-ADR (FMS) stock?
The Earnings per Share (EPS) of FRESENIUS MEDICAL CARE-ADR (FMS) is expected to grow by 21.73% in the next year.
Is the dividend of FRESENIUS MEDICAL CARE-ADR sustainable?
The dividend rating of FRESENIUS MEDICAL CARE-ADR (FMS) is 6 / 10 and the dividend payout ratio is 58.83%.